EP4081303A4 - Zusammensetzung mit cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt, verfahren zu ihrer herstellung und verwendung von cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt - Google Patents

Zusammensetzung mit cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt, verfahren zu ihrer herstellung und verwendung von cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt

Info

Publication number
EP4081303A4
EP4081303A4 EP20906765.1A EP20906765A EP4081303A4 EP 4081303 A4 EP4081303 A4 EP 4081303A4 EP 20906765 A EP20906765 A EP 20906765A EP 4081303 A4 EP4081303 A4 EP 4081303A4
Authority
EP
European Patent Office
Prior art keywords
amino acid
purine nucleoside
cyclic dipeptide
chicken extract
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20906765.1A
Other languages
English (en)
French (fr)
Other versions
EP4081303A1 (de
Inventor
Yoshihiro Nakao
Shan-May Yong
Chia-Juan Lim
Eric Kian-Shiun Shim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of EP4081303A1 publication Critical patent/EP4081303A1/de
Publication of EP4081303A4 publication Critical patent/EP4081303A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281—Proteins, e.g. gelatin or collagen
    • A23L29/284—Gelatin; Collagen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP20906765.1A 2019-12-27 2020-06-26 Zusammensetzung mit cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt, verfahren zu ihrer herstellung und verwendung von cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt Pending EP4081303A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201913617Y 2019-12-27
PCT/JP2020/025296 WO2021131106A1 (en) 2019-12-27 2020-06-26 Composition containing cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract, production method thereof, and use of cyclic dipeptide, purine nucleoside and/or amino acid, and chicken extract

Publications (2)

Publication Number Publication Date
EP4081303A1 EP4081303A1 (de) 2022-11-02
EP4081303A4 true EP4081303A4 (de) 2024-01-24

Family

ID=76573241

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20906765.1A Pending EP4081303A4 (de) 2019-12-27 2020-06-26 Zusammensetzung mit cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt, verfahren zu ihrer herstellung und verwendung von cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt

Country Status (6)

Country Link
EP (1) EP4081303A4 (de)
JP (1) JP2023508934A (de)
CN (1) CN115066273A (de)
AU (1) AU2020412909A1 (de)
TW (1) TW202123958A (de)
WO (1) WO2021131106A1 (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048850A (ja) * 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
RU2255758C2 (ru) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Биологически активный карнозин-анзеринсодержащий комплекс и способ его получения
US20070293427A1 (en) * 2006-04-21 2007-12-20 Eric Vouland Hydrolysate of avian cartilage, process of preparation and uses thereof
US20170165314A1 (en) * 2014-03-28 2017-06-15 The University Of Tokyo Agent containing imidazole dipeptide
US20190060415A1 (en) * 2017-08-31 2019-02-28 Lonza Inc. Health promoting composition and methods of use supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102248A (ja) * 2007-10-22 2009-05-14 Lytone Enterpprise Inc 血中尿酸を急速に低減させるための医薬組成物およびパッケージならびに血中尿酸を急速に低減させるためのアンセリンの使用
CN101999622A (zh) * 2009-09-01 2011-04-06 上海太太乐食品有限公司 一种液体复合调味料及其制备方法
RU2694718C1 (ru) * 2018-07-16 2019-07-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт пушного звероводства и кролиководства имени В.А. Афанасьева" (ФГБНУ НИИПЗК) Полнорационный комбикорм и способ его использования в кормлении убойного молодняка норок

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048850A (ja) * 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
RU2255758C2 (ru) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Биологически активный карнозин-анзеринсодержащий комплекс и способ его получения
US20070293427A1 (en) * 2006-04-21 2007-12-20 Eric Vouland Hydrolysate of avian cartilage, process of preparation and uses thereof
US20170165314A1 (en) * 2014-03-28 2017-06-15 The University Of Tokyo Agent containing imidazole dipeptide
US20190060415A1 (en) * 2017-08-31 2019-02-28 Lonza Inc. Health promoting composition and methods of use supplement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021131106A1 *
YUKI TAGA ET AL: "Identification of Collagen-Derived Hydroxyproline (Hyp)-Containing Cyclic Dipeptides with High Oral Bioavailability: Efficient Formation of Cyclo(X-Hyp) from X-Hyp-Gly-Type Tripeptides by Heating", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 65, no. 43, 7 October 2017 (2017-10-07), US, pages 9514 - 9521, XP055640765, ISSN: 0021-8561, DOI: 10.1021/acs.jafc.7b03714 *

Also Published As

Publication number Publication date
EP4081303A1 (de) 2022-11-02
TW202123958A (zh) 2021-07-01
WO2021131106A1 (en) 2021-07-01
JP2023508934A (ja) 2023-03-06
AU2020412909A1 (en) 2022-07-14
CN115066273A (zh) 2022-09-16

Similar Documents

Publication Publication Date Title
FI3761980T3 (fi) Aminohappoyhdisteitä ja käyttömenetelmiä
IL282026A (en) Amino acid compounds and methods of use
ZA201906063B (en) Novel 5'-inosinic acid dehydrogenase and method of preparing 5'-inosinic acid using the same
PH12018502714A1 (en) Nicotine particles and compositions
EP3845247A4 (de) Anwendung eins aminosäurenährstoffs und pharmazeutische zusammensetzung mit einem aminosäurenährstoff
SG11202002185SA (en) Novel promoter and l-amino acid production method using same
FI3630977T3 (fi) Menetelmiä ja koostumuksia ei-luonnollisen aminohapon sisältävän proteiinin tuotannon edistämiseksi
EP3766521A4 (de) Pharmazeutische zusammensetzung mit 211at-markiertem aminosäurederivat und verfahren zur herstellung dieser pharmazeutischen zusammensetzung
HK1246279A1 (zh) C14-位羥基酯化的雷公藤甲素氨基酸衍生物、及其製備方法和應用
PH12017501444A1 (en) (2r,4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
SG11202003370VA (en) Use of amino acid supplementation for improved muscle protein synthesis
EP3925968A3 (de) Aus hsp70 gewonnenes peptid, pharmazeutische zusammensetzung zur behandlung oder vorbeugung von krebs unter verwendung davon, immunitätsinduzierer und verfahren zur herstellung von antigen-präsentierender zelle
IL292047A (en) Proteins containing various, multiple unnatural amino acids and methods for preparing and using such proteins
EP3773900A4 (de) Hinokitiol-analoga, verfahren für die zubereitung und pharmazeutische zusammensetzungen daraus
EP4081303A4 (de) Zusammensetzung mit cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt, verfahren zu ihrer herstellung und verwendung von cyclischem dipeptid, purinnucleosid und/oder aminosäure sowie hühnerextrakt
HK1250726A1 (zh) 含有氨基酸及環狀二肽的組合物
MY202141A (en) Peptide mapping method for sequence identification of insulin & insulin analogues
MX2018005199A (es) Productos para el cuidado bucal y metodos que comprenden hlps.
EP3648836A4 (de) Verfahren und system zur veränderung der körpermassezusammensetzung unter verwendung von galvanischer vestibulärer stimulation
HUE051312T2 (hu) Új foszfotriazol MRNS-5'-vég-sapka-analógok, ezt tartalmazó kompozíció, ezt tartalmazó RNS-molekula, alkalmazásaik, valamint eljárás RNS-molekula, protein vagy peptid szintetizálására
EP3882256A4 (de) Verfahren zur herstellung von n-acetyl-dipeptiden und n-acetyl-aminosäure
EP4087656A4 (de) Zusammensetzung mit peptiden, verfahren zu ihrer herstellung und ihre verwendung
GB202110503D0 (en) Method to produce novel amino acid
GB201912545D0 (en) Biophysical method for the synthesis of natural and artificial dnas,proteins and other biopolymers
HK1248724A1 (zh) 肽或其鹽及其製備方法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220715

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240103

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/708 20060101ALI20231220BHEP

Ipc: A61K 31/405 20060101ALI20231220BHEP

Ipc: A61K 38/12 20060101ALI20231220BHEP

Ipc: A23L 33/18 20160101ALI20231220BHEP

Ipc: A23L 33/175 20160101ALI20231220BHEP

Ipc: A23L 33/10 20160101ALI20231220BHEP

Ipc: A61P 29/00 20060101AFI20231220BHEP